Stronger than Ozempic. Not exactly legal. ‘Reta’ has entered the chat.
An unapproved weight-loss drug is gaining attention for its powerful effects and potential health risks.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Reports surfaced regarding an unlicensed and experimental weight-loss drug known as ‘Reta’ being sold at a Brooklyn bodega. The substance was linked to liver damage, yellowing of the eyes, and a wave of hospitalisations.
Epilogue added 17d ago, after coverage quieted.
The brief
A weight-loss drug known as 'Reta' is trending due to its reported potency and legal status. Coverage from LADbible, AOL.com, The Sun, CBS News, and The Washington Post highlights the drug's availability in unexpected places, such as a Brooklyn bodega. The Washington Post and CBS News explore the broader implications of the drug's popularity.
The coverage emphasizes the drug's unapproved status and the health risks associated with its use. The Washington Post and CBS News delve into the societal factors driving the demand for such powerful weight-loss solutions. Watch for further developments on the regulatory response to 'Reta' and potential health advisories.
Coverage does not yet specify any official statements or actions from health authorities.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (78% supported) Updated 21d ago.
Quick answers
What is 'Reta'?
'Reta' is an experimental weight-loss drug that is not approved for use.
What are the reported side effects of 'Reta'?
Reported side effects include yellowing of the eyes and liver damage.
Where has 'Reta' been reported to be sold?
Coverage from AOL.com and CBS News mentions that 'Reta' has been sold at a Brooklyn bodega.
Coverage (6)
- The weight loss ‘quick fix’ driving a wave of hospitalisations AFR · 22d ago
- Woman issues warning after eyes went yellow when taking 'world's most powerful weight-loss drug' LADbible · 22d ago
- "Here for the peptides": Unapproved weight-loss drug sold at Brooklyn bodega AOL.com · 22d ago
- 'Godzilla' fat jab linked to liver damage as unlicensed drug turns users yellow The Sun · 22d ago
- What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug CBS News · 22d ago
- Stronger than Ozempic. Not exactly legal. ‘Reta’ has entered the chat. The Washington Post · 22d ago
Topics
Related trends
Pharmacists Warn About Diet on Weight Loss Drugs
Pharmacists and health outlets are spotlighting specific nutritional adjustments for patients using GLP-1 weight loss medications.
Weight loss drugs linked to increased risk of hair loss, researchers say
New research has identified a potential link between GLP-1 weight loss medications like Ozempic and Mounjaro and an increased risk of hair loss.
GLP-1 use rising rapidly among US adolescents and young adults, study finds
GLP-1 weight-loss medications are seeing a rapid surge in use among U.S. adolescents and young adults.
GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
New economic research identifies a correlation between GLP-1 weight-loss drug usage and a 17% reduction in employee sick leave.
Georgia woman part of lawsuit claiming link between GLP-1 weight loss drugs and blindness - WSB-TV
Reports and litigation are emerging over a potential link between GLP-1 weight loss medications and a rare, blinding eye condition.
This GLP-1 retreat changed how I think about weight loss
GLP-1 medications are sparking broader conversations about weight loss retreats, medical benefits beyond weight, and the psychological impact of stigma.